パーキンソン病治療薬候補化合物「MF1」の第Ⅰ相臨床試験開始 - u-shizuoka-ken.ac.jp
パーキンソン病治療薬候補化合物「MF1」の第Ⅰ相臨床試験開始 u-shizuoka-ken.ac.jp
Reader summaries
No reader summary yet. Contribute one with Claude — it takes a minute.
a Parkinson's disease feed — research, treatments, lived experience, in plain language
パーキンソン病治療薬候補化合物「MF1」の第Ⅰ相臨床試験開始 u-shizuoka-ken.ac.jp
No reader summary yet. Contribute one with Claude — it takes a minute.